Metastatic efficiency of tumour cells can be impaired by intraoperative cell salvage process: truth or conjecture?

Transfusion Medicine

Volumn 27, Issue 5, 2017, Pages 327-334

  Kumar, N ^a   Zaw, A S ^a   Kantharajanna, S B ^a   Khoo, B L ^b   Lim, C T ^b   Thiery, J P ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

circulating tumour cells; intraoperative cell salvage; oncological surgery

Indexed keywords

APPLIED RESEARCH; BASIC RESEARCH; BLOOD SAFETY; BLOOD SALVAGE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURGERY; CELL VIABILITY; CIRCULATING TUMOR CELL; CIRCULATION; HUMAN; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; INTRAOPERATIVE PERIOD; MALIGNANT NEOPLASM; MEDLINE; METASTASIS; METASTASIS POTENTIAL; MICROMETASTASIS; NONHUMAN; PRIMARY TUMOR; PROSPECTIVE STUDY; REVIEW; SCOPUS; SYSTEMATIC REVIEW; TARGET ORGAN; TUMOR SEEDING; ANIMAL; METABOLISM; NEOPLASM; PATHOLOGY; PROCEDURES; TUMOR EMBOLISM;

ANIMALS; BLOOD SAFETY; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; OPERATIVE BLOOD SALVAGE;

EID: 85032281541     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/tme.12453     Document Type: Review

References (83)

1. Aceto, N., Bardia, A., Miyamoto, D.T. et al. (2014) Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell, 158, 1110–1122.
2. Allan, A.L. & Keeney, M. (2010) Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. Journal of Oncology, 2010, 426218.
3. Allard, W.J., Matera, J., & Miller, M.C. (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clinical Cancer Research, 10, 6897–6904.
4. Beck-Schimmer, B., Romero, B., Booy, C., Josh, H., Hallers, U., Pasch, T. & Spahn, D.R. (2004) Release of inflammatory mediators in irradiated cell salvage blood and their biological consequences in human beings following transfusion. European Journal of Anaesthesiology, 21, 46–52.
5. Benoy, I.H., Elst, H., Philips, M. et al. (2006) Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer. British Journal of Cancer, 94, 672–680.
6. Bower, M.R., Ellis, S.F., Scoggins, C.R., McMasters, K.M. & Martin, R.C. (2011) Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. Annals of Surgical Oncology, 18, 166–173.
7. Butler, T.P. & Gullino, P.M. (1975) Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Research, 35, 512–516.
8. Catling, S., Williams, S., Freites, O., Rees, M., Davies, C. & Hopkins, L. (2008) Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia, 63, 1332–1338.
9. Chambers, A.F., Groom, A.C., Mcdonald, I.C. (2002) Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer, 2, 563–572.
10. Chambers, A.F., Naumov, G.N., Varghese, H.J., Nadkarni, K.V., MacDonald, I.C. & Groom, A.C. (2001) Critical steps in hematogenous metastasis: an overview. Surgical Oncology Clinics of North America, 10, 243–255, vii.
11. Chen, J.F., Ho, H., Lichterman, J. et al. (2015) Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases. Cancer, 121, 3240–3251.
12. Cohen, S.J., Punt, C.J., Iannotti, N. et al. (2009) Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Annals of Oncology, 20, 1223–1229.
13. Connor, J.P., Morris, P.C., Alagoz, T., Anderson, B., Bottles, K. & Buller, R.E. (1995) Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix. Obstetrics and Gynecology, 86, 373–378.
14. Cristofanilli, M., Budd, G.T., Ellis, M.J. et al. (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. The New England Journal of Medicine, 351, 781–791.
15. Cristofanilli, M., Hayes, D.F., Budd, G.T. et al. (2005) Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. Journal of Clinical Oncology, 23, 1420–1430.
16. Dale, R.F., Kipling, R.M., Smith, M.F., Collier, D.S. & Smith P.J. (1988) Separation of malignant cells during autotransfusion. The British Journal of Surgery, 75, 581.
17. Danila, D.C., Heller, G., Gignac, G.A. et al. (2007) Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clinical Cancer Research, 13, 7053–7058.
18. Daskalaki, A., Agelaki, S., Perraki, M. et al. (2009) Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer. British Journal of Cancer, 101, 589–597.
19. Davis, M., Sofer, M., Gomez-Marin, O., Bruck, D. & Soloway, M.S. (2003) The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence? BJU International, 91, 474–476.
20. de, Bono, J.S., Scher, H.I., Montgomery, R.B. et al. (2008) Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clinical Cancer Research, 14, 6302–6309.
21. De Giorgi, U., Valero, V., Rohren, E. et al. (2010) Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer. Annals of Oncology, 21, 33–39.
22. Fidler, I.J., Gersten, D.M. & Hart, I.R. (1978) The biology of cancer invasion and metastasis. Advances in Cancer Research, 28, 149–250.
23. Foltys, D., Zimmermann, T., Heise, M. et al. (2011) Liver transplantation for hepatocellular carcinoma – is there a risk of recurrence caused by intraoperative blood salvage autotransfusion. European Surgical Research, 47, 182–187.
24. Ford, B.S., Sharma, S., Rezaishiraz, H., Huben, R.S. & Mohler, J.L. (2008) Effect of perioperative blood transfusion on prostate cancer recurrence. Urologic Oncology, 26, 364–367.
25. Fujimoto, J., Okamoto, E., Yamanaka, N., Oriyama, T., Furukawa, K., Kawamura, E., Tanaka, T. & Tomoda, F. (1993) Efficacy of autotransfusion in hepatectomy for hepatocellular carcinoma. Archives of Surgery, 128, 1065–1069.
26. Gaforio, J.J., Serrano, M.J., Sanchez-Rovira, P. et al. (2003) Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis. International Journal of Cancer, 107, 984–990.
27. Gorin, M.A., Eldefrawy, A., Manoharan, M. & Soloway, M.S. (2012) Oncologic outcomes following radical prostatectomy with intraoperative cell salvage. World Journal of Urology, 30, 379–383.
28. Gray, C.L., Amling, C.L., Polston, G.R., Powell, C.R. & Kane, C.J. (2001) Intraoperative cell salvage in radical retropubic prostatectomy. Urology, 58, 740–745.
29. Gwak, M.S., Lee, K.W., Kim, S.Y. et al. (2005) Can a leukocyte depletion filter (LDF) reduce the risk of reintroduction of hepatocellular carcinoma cells? Liver Transplantation, 11, 331–335.
30. Hansen, E., Wolff, N., Knuechel, R., Ruschoff, J., Hofstaedter, F. & Taeger, K. (1995) Tumor cells in blood shed from the surgical field. Archives of Surgery, 130, 387–393.
31. Hart, O.J. 3rd, Klimberg, I.W., Wajsman, Z. & Baker, J. (1989) Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder. Surgery, Gynecology & Obstetrics, 168, 302–306.
32. Hirano, T., Yamanaka, J., Iimuro, Y. & Fujimoto, J. (2005) Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma. Surgery Today, 35, 1042–1046.
33. Hong, Y., Fang, F. & Zhang, Q. (2016) Circulating tumor cell clusters: what we know and what we expect (review). International Journal of Oncology, 49, 2206–2216.
34. Ignatiadis, M., Xenidis, N., Perraki M. et al. (2007) Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. Journal of Clinical Oncology, 25, 5194–5202.
35. Karczewski, D.M., Lema, M.J. & Glaves, D. (1994) The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery. Anesthesia and Analgesia, 78, 1131–1135.
36. Khoo, B.L., Chaudhuri, P.K., Ramalingam, N., Tan, D.S.W., Lim, C.T. & Warkiani, M.E. (2016) Single-cell profiling approaches to probing tumor heterogeneity. International journal of cancer, 139, 243–255.
37. Khoo, B.L., Warkiani, M.E., Tan, D.S. et al. (2014) Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells. PLoS One, 9, e99409.
38. Kim, J.M., Kim, G.S., Joh, J.W. et al. (2012) Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transplant International, 26, 84–89.
39. Kim, J.M., Kim, G.S., Jow, J.W. et al. (2013) Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transplant International, 26, 84–89.
40. Klimberg, I., Sirois, R., Wajsman, Z. & Baker, J. (1986) Intraoperative autotransfusion in urologic oncology. Archives of Surgery, 121, 1326–1329.
41. Klimberg, I.W. (1989) Autotransfusion and blood conservation in urologic oncology. Seminars in Surgical Oncology, 5, 286–292.
42. Krebs, M.G., Sloane, R., Priest, L. et al. (2011) Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. Journal of Clinical Oncology, 29, 1556–1563.
43. Kumar, N., Ahmed, Q., Lee, V.K. et al. (2014) Can there be a place for intraoperative salvaged blood in spine tumor surgery? Annals of Surgical Oncology, 21, 2436–2443.
44. Kumar, N., Ahmed, Q., Lee, V.K., Zaw, A.S., Goy, R., & Wong, H.K. (2016) Are we ready for the use of intraoperative salvaged blood in metastatic spine tumour surgery?. European Spine Journal, 25, 3997–4007.
45. Kumar, N., Chen, Y., Zaw, A.S., Nayak, D., Ahmed, Q., Soong, R. & Wong, H.K. (2014) Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review. The Lancet Oncology, 15, e33–e41.
46. Kumar, N., Lam, R., Zaw, A.S., Malhotra, R., Tan, J., Tan, G. & Setiobudi, T. (2014) Flow cytometric evaluation of the safety of intraoperative salvaged blood filtered with leucocyte depletion filter in spine tumour surgery. Annals of Surgical Oncology, 21, 4330–4335.
47. Kumar, N., Zaw, A.S., Khoo, B.L., Nandi, S., Lai, Z., Singh, G., Lim, C.T. & Thiery, J.P. (2016) Intraoperative cell salvage in metastatic spine tumour surgery reduces potential for reinfusion of viable cancer cells. European Spine Journal, 25, 4008–4015.
48. Lane, T.A. (1989) The effect of storage on the metastatic potential of tumor cells collected in autologous blood. An animal model. Transfusion, 29, 418–420.
49. Langley, R.R. & Fidler, I.J. (2007) Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocrine Reviews, 28, 297–321.
50. Liang, J., Shen, J., Chua, S. et al. (2015) Does intraoperative cell salvage system effectively decrease the need for allogeneic transfusions in scoliotic patients undergoing posterior spinal fusion? A prospective randomized study. European Spine Journal, 24, 270–275.
51. Liang, T.B., Li, D.L., Liang, L. et al. (2008) Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells. Transplantation, 85, 863–869.
52. Liu, M.C., Shields, P.G., Warren, R.D. et al. (2009) Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. Journal of Clinical Oncology, 27, 5153–5159.
53. Lucci, A., Hall, C.S., Lodhi, A.K. et al. (2012) Circulating tumour cells in non-metastatic breast cancer: a prospective study. The Lancet Oncology, 13, 688–695.
54. MacIvor, D., Nelson, J. & Triulzi, D. (2009) Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy. Transfusion, 49, 1431–1434.
55. Martin, R.C., Wellhausen, S.R., Moehle, D.A., Martin, A.W. & McMasters, K.M. (2005) Evaluation of intraoperative autotransfusion filtration for hepatectomy and pancreatectomy. Annals of Surgical Oncology, 12, 1017–1024.
56. McKenna, S.J. (1986) Autologous blood transfusions. Council on scientific affairs. JAMA, 256, 2378–2380.
57. Mirhashemi, R., Averette, H.E., Deepika, K., Estape, R., Angioli, R., Martin, J., Rodriguez, M. & Penalver, M.A. (1999). The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer. American Journal of Obstetrics and Gynecology 181, 1310–1315; discussion 1315–1316.
58. Morris, V.L., Schmidt, E.E., MacDonald, I.C., Groom, A.C. & Chambers, A.F. (1997) Sequential steps in hematogenous metastasis of cancer cells studied by in vivo videomicroscopy. Invasion & Metastasis, 17, 281–296.
59. Muscari, F., Suc, B., Vigouroux, D. et al. (2005) Blood salvage autotransfusion during transplantation for hepatocarcinoma: does it increase the risk of neoplastic recurrence? Transplant International, 18, 1236–1239.
60. Naito, S., Giavazzi, R. & Fidler, I.J. (1987) Correlation between the in vitro interaction of tumor cells with an organ environment and metastatic behavior in vivo. Invasion & Metastasis, 7, 16–29.
61. Nicolson, G.L. (1988) Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochimica et Biophysica Acta, 948, 175–224.
62. Nieder, A.M., Carmack, A.J., Sved, P.D., Kim, S.S., Manoharan, M. & Soloway, M.S. (2005) Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. Urology, 65, 730–734.
63. Nieder, A.M., Manoharan, M., Yang, Y. & Soloway, M.S. (2007) Intraoperative cell salvage during radical cystectomy does not affect long-term survival. Urology, 69, 881–884.
64. Paget, S. (1889) The distribution of secondary growths in cancer of the breast. The Lancet, 133, 571–573.
65. Pantel, K. & Brakenhoff, R.H. (2004) Dissecting the metastatic cascade. Nature Reviews. Cancer, 4, 448–456.
66. Park, K.I., Kojima, O. & Tomoyoshi, T. (1997) Intra-operative autotransfusion in radical cystectomy. British Journal of Urology, 79, 717–721.
67. Perseghin, P., Vigano, M., Rocco, G., Pona, C., Buscemi, A. & Rizzi, A. (1997) Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients. Vox Sanguinis, 72, 221–224.
68. Pierga, J.Y., Bidard, F.C., Mathiot, C. et al. (2008) Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clinical Cancer Research, 14, 7004–7010.
69. Pierga, J.Y., Bonneton, C., Vincent-Salomon, A. et al. (2004) Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clinical Cancer Research, 10, 1392–1400.
70. Poli, M., Camargo, A., Villa, L., Moura, R., Colella, R. & Deheinzelin, D. (2008) Intraoperative autologous blood recovery in prostate cancer surgery: in vivo validation using a tumour marker. Vox Sanguinis, 95, 308–312.
71. Poste, G. & Fidler, I.J. (1980) The pathogenesis of cancer metastasis. Nature, 283, 139–146.
72. Price, J.E., Naito, S. & Fidler, I.J. (1988) Growth in an organ microenvironment as a selective process in metastasis. Clinical & Experimental Metastasis, 6, 91–102.
73. Stoffel, J.T., Topjian, L. & Libertino, J.A. (2005) Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy. BJU International, 96, 313–315.
74. Talmadge, J.E. & Fidler, I.J. (2010) AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Research, 70, 5649–5669.
75. Tanaka, K., Toiyama, Y., Okugawa, Y. et al. (2014) In vivo optical imaging of cancer metastasis using multiphoton microscopy: a short review. American Journal of Translational Research, 6, 179–187.
76. Varghese, H.J., Mackenzie, L.T., Groom, A., Ellis, C., Ryan, A., Macdonald, I. & Chambers, A. (2004) In vivo videomicroscopy reveals differential effects of the vascular-targeting agent ZD6126 and the anti-angiogenic agent ZD6474 on vascular function in a liver metastasis model. Angiogenesis, 7, 157–164.
77. Warkiani, M.E., Guan, G., Luan, K.B. et al. (2014) Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells. Lab on a Chip, 14, 128–137.
78. Warkiani, M.E., Khoo, B.L., Wu, L., Tay, A.K.P., Bhagat, A.A.S., Han, J. & Lim, C.T. (2016) Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics. Nature Protocols, 11, 134–148.
79. Waters, J.H., Yazer, M., Chen, Y.F. & Kloke, J. (2012) Blood salvage and cancer surgery: a meta-analysis of available studies. Transfusion, 52, 2167–2173.
80. Weiss, L. (1990) Metastatic inefficiency. Advances in Cancer Research, 54, 159–211.
81. Woodhouse, E.C., Chuaqui, R.F. & Liotta, L.A. (1997) General mechanisms of metastasis. Cancer, 80, 1529–1537.
82. Wulfing, P., Borchard, J., Buerger, H., Heidl, S., Zänker, K.S., Kiesel, L. & Brandt, B. (2006) HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients. Clinical Cancer Research, 12, 1715–1720.
83. Yaw, P.B., Sentany, M., Link, W.J., Wahle, W.M. & Glover, J.L. (1975) Tumor cells carried through autotransfusion. Contraindication to intraoperative blood recovery? JAMA, 231, 490–491.